← Leaderboards
William R Waud
Southern Research Institute
$1,687,597
Attributed
$1,687,597
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,687,597 · 3
By mechanism
N01$925,824 · 1
P01$761,773 · 1
U19$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Southern Research Institute
Same institution · by research overlap
- William B Parker$3,366,132
- John A Secrist$6,038,272
- Rongbao Li$2,841,782
- Robert F Struck$1,662,879
- Kamal N Tiwari$761,773
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationAntineoplasticsLaboratory MouseNeoplasm /Cancer ChemotherapyBiomedical FacilityNeoplasm /Cancer TransplantationNucleoside AnalogCell LinePharmacokineticsEscherichia ColiCooperative StudyIsozymesDisease /Disorder ModelDosageProdrugsPurine AnalogPurine NucleosidesTissue /Cell CultureToxicologyTransfection /Expression VectorAthymic MouseXenotransplantationBiological ModelsChemical Structure Function
Grant awards (9)
CORE--CHEMOTHERAPY AND TOXICOLOGY$228,401
P01 · FY2002 · CA
CORE--CHEMOTHERAPY$0
U19 · FY2002 · CA
CORE--CHEMOTHERAPY AND TOXICOLOGY$228,401
P01 · FY2001 · CA
CORE--CHEMOTHERAPY$0
U19 · FY2001 · CA
DETAILED DRUG EVALUATION &DEVELOPMENT OF TREATMENT STRA$617,216
N01 · FY2000 · CM
DETAILED DRUG EVALUATION &DEVELOPMENT OF TREATMENT STRA$308,608
N01 · FY2000 · CM
CORE--CHEMOTHERAPY AND TOXICOLOGY$304,971
P01 · FY2000 · CA
CORE--CHEMOTHERAPY$0
U19 · FY2000 · CA
DETAILED DRUG EVALUATION &DEVELOPMENT OF TREATMENT STRA$0
N01 · FY2000 · CM